Synthesis of Hydrazides Derivatives as Anti-Mycobacterial Agents Mediated by the Environmental-Friendly Organocatalyst

References

1. EldehnaW. FaresM. Abdel-AzizM. Abdel-AzizH. Design, synthesis and antitubercular activity of certain nicotinic Acid hydrazides.Molecules20152058800881510.3390/molecules2005880025988611
   [Google Scholar]
2. HanM.I. GürolG. YildirimT. KalayciS. ŞahinF. Synthesis and antibacterial activity of hnew hydrazide-hydrazones derived from Benzocaine.MARMARA Pharm. J.201721496196610.12991/mpj.2017.34
   [Google Scholar]
3. MalhotraM. SharmaS. DeepA. Synthesis, characterization and antimicrobial evaluation of novel derivatives of isoniazid.Med. Chem. Res.20122171237124410.1007/s00044‑011‑9634‑0
   [Google Scholar]
4. JudgeV. NarasimhanB. AhujaM. SriramD. YogeesariP. De ClercqE. Synthesis, antimycobacterial, antiviral, antimicrobial activity and QSAR studies of N2-acyl isonicotinic acid hydrazide derivatives.Med. Chem. (Los Angeles)201391537610.2174/1573406411309010053
   [Google Scholar]
5. MalhotraM. MongaV. SharmaS. JainJ. SamadA. StablesJ. DeepA. Synthesis, characterization and pharmacological evaluation of (E)-N′-(substituted-benzylidene)isonicotinohydrazide derivatives as potent anticonvulsant agents.Med. Chem. Res.20122192145215210.1007/s00044‑011‑9739‑5
   [Google Scholar]
6. MaccariR. OttanàR. VigoritaM.G. In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14.Bioorg. Med. Chem. Lett.200515102509251310.1016/j.bmcl.2005.03.06515863306
   [Google Scholar]
7. SinhaN. JainS. TilekarA. Synthesis and antimycobacterial activity of some N, N′-disubstituted isonicotino hydrazide derivatives.Arkivoc200520052911
   [Google Scholar]
8. HuY.Q. ZhangS. ZhaoF. GaoC. FengL.S. LvZ.S. WuX. Isoniazid derivatives and their anti-tubercular activity.Eur. J. Med. Chem.201713325526710.1016/j.ejmech.2017.04.002
   [Google Scholar]
9. ShaharyarM. SiddiquiA.A. AliM.A. SriramD. YogeeswariP. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4′-hydroxy-3′-methyl phenyl)-5-[(sub) phenyl]-2-pyrazolines.Bioorg. Med. Chem. Lett.200616153947394910.1016/j.bmcl.2006.05.024
   [Google Scholar]
10. ArumugamN. AlmansourA.I. KumarR.S. KrishnaV.S. SriramD. PadmanabanR. A stereo, regioselective synthesis and discovery of antimycobaterium tuberculosis activity of novel β-lactam grafted spirooxindolopyrrolidine hybrid heterocycles.Arab. J. Chem.202114210293810.1016/j.arabjc.2020.102938
    [Google Scholar]
11. HassanN.W. SaudiM.N. Abdel-GhanyY.S. IsmailA. ElzahharP.A. SriramD. NassraR. Abdel-AzizM.M. El-HawashS.A. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.Bioorg. Chem.20209610361010.1016/j.bioorg.2020.10361032028062
    [Google Scholar]
12. SlaydenR.A. LeeR.E. BarryC.E. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.Mol. Microbiol.200038351452510.1046/j.1365‑2958.2000.02145.x11069675
    [Google Scholar]
13. TimminsG.S. DereticV. Mechanisms of action of isoniazid.Mol. Microbiol.20066251220122710.1111/j.1365‑2958.2006.05467.x17074073
    [Google Scholar]
14. SureramS. SenadeeraS.P.D. HongmaneeP. MahidolC. RuchirawatS. KittakoopP. Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.Bioorg. Med. Chem. Lett.20122282902290510.1016/j.bmcl.2012.02.053
    [Google Scholar]
15. GanihigamaD.U. SureramS. SangherS. HongmaneeP. AreeT. MahidolC. RuchirawatS. KittakoopP. Antimycobacterial activity of natural products and synthetic agents: Pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.Eur. J. Med. Chem.20158911210.1016/j.ejmech.2014.10.02625462220
    [Google Scholar]
16. AmmajiS. MasthanammaS. BhandareR.R. AnnaduraiS. ShaikA.B. Antitubercular and antioxidant activities of hydroxy and chloro substituted chalcone analogues: Synthesis, biological and computational studies.Arab. J. Chem.202215210358110.1016/j.arabjc.2021.103581
    [Google Scholar]
17. AdnanD. SinghB. MehtaS.K. KumarV. KatariaR. Simple and solvent free practical procedure for chalcones: An expeditious, mild and greener approach.Curr. Res. Green Sustain. Chem.2020310004110.1016/j.crgsc.2020.100041
    [Google Scholar]
18. OliveiraP. GuidettiB. ChamayouA. André-BarrèsC. MadackiJ. KordulákováJ. MoriG. OrenaB. ChiarelliL. PascaM. LherbetC. CarayonC. MassouS. BaronM. BaltasM. Mechanochemical synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.Molecules2017229145710.3390/molecules2209145728862683
    [Google Scholar]
19. WaghY.B. DalalK.S. PadviS.A. TerdaleS.S. DalalD.S. MahulikarP.P. Efficient and greener synthesis of functionalized isoniazid azomethines from aromatic aldehydes and isatins using citric acid in aqueous ethanol.Polycycl. Aromat. Compd.202343142143310.1080/10406638.2021.2015396
    [Google Scholar]
20. JiangJ. CaiY. ChenW. LinL. LiuX. FengX. Enantioselective aza-Michael reaction of hydrazide to chalcones through the nonactivated amine moiety conjugated addition.Chem. Commun. (Camb.)201147134016401810.1039/c0cc05804a21344091
    [Google Scholar]
21. DabiriM. SalehiP. BaghbanzadehM. BahramnejadM. A facile procedure for the one-pot synthesis of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles.Tetrahedron Lett.200647396983698610.1016/j.tetlet.2006.07.127
    [Google Scholar]
22. HasanH. AkhterM. AkhterW. AliI. ZaheenM. AhsanI. MahmoodD. Design and synthesis of novel N-substituted-3-chloro-2-azetidinone derivatives as potential anticonvulsant agents.Med. Chem. Res.20112081357136310.1007/s00044‑010‑9485‑0
    [Google Scholar]
23. CravottoG. CintasP. Power ultrasound in organic synthesis: Moving cavitational chemistry from academia to innovative and large-scale applications.Chem. Soc. Rev.200635218019610.1039/B503848K16444299
    [Google Scholar]
24. ElkanziN.A.A. HrichiH. AlolayanR.A. DerafaW. ZahouF.M. BakrR.B. Synthesis of chalcones derivatives and their biological activities: A review.ACS Omega2022732277692778610.1021/acsomega.2c0177935990442
    [Google Scholar]
25. ZhaoP. ZhangX. DuP. LiG. Susceptibility profiles of Nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay.Sci. Rep.201736236236610.1128/JCM.36.2.362‑366.1998
    [Google Scholar]
26. KrishnaV.S. ZhengS. RekhaE.M. GuddatL.W. SriramD. Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads.J. Comput. Aided Mol. Des.201933335736610.1007/s10822‑019‑00184‑130666485
    [Google Scholar]
27. ReckF. AlmR.A. BrassilP. NewmanJ.V. CiaccioP. McNultyJ. BarthlowH. GotetiK. BreenJ. Comita-PrevoirJ. CroninM. EhmannD.E. GengB. GodfreyA.A. FisherS.L. Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): Antibacterial agents with an improved safety profile.J. Med. Chem.201255156916693310.1021/jm300690s22779424
    [Google Scholar]